Intravenous vitamin C monotherapy in critically ill patients: a systematic review and meta-analysis of randomized controlled trials with trial sequential analysis.
Zheng-Yii LeeLuis Alfonso Ortiz-ReyesCharles Chin Han LewM Shahnaz HasanLu KeJayshil J PatelChristian StoppeDaren K HeylandPublished in: Annals of intensive care (2023)
IVVC monotherapy may be associated with mortality benefits in critically ill patients, particularly in patients with a high risk of dying. Given the low certainty of evidence, this potentially life-saving therapy warrants further studies to identify the optimal timing, dosage, treatment duration, and patient population that will benefit most from IVVC monotherapy. PROSPERO Registration ID: CRD42022323880. Registered 7th May 2022.